血管浮腫治療の世界市場レポート 2025年

血管浮腫治療市場規模は、今後数年で急成長が見込まれます。2029年にはCAGR14.6％で54億米ドルに成長します。予測期間中に予測される成長は、ヘルスケア支出の増加、アレルギーに対する意識の高まり、慢性疾患の負担増、血管浮腫の発生率と有病率の増加、個別化医療の重視の高まりに関連しています。この期間に予想される主要動向には、診断技術の発展、機械学習の統合、研究開発への投資の増加、遠隔医療の採用、規制当局の承認と市場参入の加速などがあります。

希少疾患の発生率の増加が、今後数年間の血管浮腫治療市場の成長を促進すると予測されます。希少疾患は、人口のごく一部が罹患する病態であり、しばしば重大な健康課題とともに限られた治療選択肢を提示します。この増加は、遺伝子検査や診断技術の進歩によるところが大きく、以前は発見されなかった病態をより正確に同定・診断できるようになり、その結果、報告されている有病率が高くなっています。血管性浮腫治療は、重度の腫脹エピソードの予防と制御に役立つ標的治療を提供することにより、遺伝性血管性浮腫のような希少疾患の管理に重要な役割を果たし、最終的に患者の転帰を向上させています。例えば、2024年11月、米国食品医薬品局は、7,000を超える希少疾患が米国の3,000万人以上の人々に影響を及ぼしていると報告しました。このように、希少疾患の罹患率の増加が血管浮腫治療市場の拡大に寄与しています。

血管浮腫治療市場の主要企業は、急性遺伝性血管性浮腫（HAE）発作を経験している患者をより便利で迅速に救済するために、皮下注射などの革新的なソリューションの開発を優先しています。皮下注射は、皮膚の下にある脂肪組織に薬剤を投与し、血流に徐々に吸収させています。例えば、2025年4月、オーストラリアを拠点とするバイオテクノロジー企業CSL Limitedは、急性HAE発作を予防するために設計された新規の完全ヒトモノクローナル抗体であるANDEMBRY（ガラダシマブ）を発表しました。ANDEMBRYは、月1回の皮下投与が承認された初めての充填済みペンで、簡便な長期予防の選択肢を記載しています。この薬剤は、血管性浮腫を誘発する経路の重要なコンポーネントである活性化第XII因子（第XIIa因子）を阻害することにより作用します。この技術革新は、患者中心の効果的な疾患管理を実現することで、HAE治療における大きな前進を意味します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、貿易戦争と関税、コロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の血管浮腫治療：PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の血管浮腫治療市場：成長率分析
• 世界の血管浮腫治療市場の実績：規模と成長、2019～2024年
• 世界の血管浮腫治療市場の予測：規模と成長、2024～2029年、2034年
• 世界の血管浮腫治療：総潜在市場規模（TAM）

第6章 市場セグメンテーション

• 世界の血管浮腫治療市場：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• アレルギー性血管性浮腫
• 薬剤誘発性血管性浮腫
• 特発性血管性浮腫
• 遺伝性血管性浮腫
• 世界の血管浮腫治療市場：投与経路別、実績と予測、2019～2024年、2024～2029年、2034年
• 注射
• 経口
• 世界の血管浮腫治療市場：最終用途別、実績と予測、2019～2024年、2024～2029年、2034年
• 病院
• クリニック
• 研究機関
• 世界の血管浮腫治療市場、アレルギー性血管性浮腫のサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 抗ヒスタミン薬
• コルチコステロイド
• エピネフリン
• 免疫療法
• アレルゲン回避療法
• 世界の血管浮腫治療市場、薬剤誘発性血管性浮腫のサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 原因薬剤の中止
• 抗ヒスタミン薬
• コルチコステロイド
• エピネフリン
• ブラジキニン経路阻害剤
• 世界の血管浮腫治療市場、特発性血管性浮腫のサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 経験的抗ヒスタミン療法
• コルチコステロイド療法
• ロイコトリエン受容体拮抗薬
• モノクローナル抗体
• 観察と症状管理
• 世界の血管浮腫治療市場、遺伝性血管性浮腫のサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• C1エステラーゼ阻害剤補充療法
• ブラジキニンB2受容体拮抗薬
• カリクレイン阻害剤
• 弱毒化アンドロゲン
• 抗線溶薬

第7章 地域別・国別分析

• 世界の血管浮腫治療市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界の血管浮腫治療市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 血管浮腫治療市場：競合情勢
• 血管浮腫治療市場：企業プロファイル
  • Sanofi SA
  • Takeda Pharmaceutical Company Limited
  • Viatris Inc.
  • Otsuka Pharmaceutical Co. Ltd.
  • Fresenius Kabi AG

第31章 その他の大手企業と革新的企業

• Bausch Health Companies Inc.
• Apotex Inc.
• Aurobindo Pharma Ltd.
• Dr. Reddy's Laboratories Ltd
• Cipla Inc.
• Alnylam Pharmaceuticals Inc
• Ionis Pharmaceuticals Inc.
• Salix Pharmaceuticals Ltd
• BioCryst Pharmaceuticals Inc.
• Pharming Group NV
• Pharvaris Netherlands B.V
• Astria Therapeutics
• Intellia Therapeutics
• KalVista Pharmaceuticals Ltd.
• ADARx Pharmaceuticals

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、戦略

• 血管浮腫治療市場、2029年：新たな機会を提供する国
• 血管浮腫治療市場、2029年：新たな機会を提供するセグメント
• 血管浮腫治療市場、2029年：成長戦略
  • 市場動向による戦略
  • 競合の戦略

第36章 付録

Angioedema treatment involves the medical management of swelling beneath the skin or mucous membranes, which is often triggered by allergic reactions, side effects of medications, genetic disorders, or sometimes unknown factors. The goal of treatment is to alleviate symptoms, prevent airway blockage, and reduce the frequency and severity of episodes.

The primary categories of angioedema treatment include allergic angioedema, drug-induced angioedema, idiopathic angioedema, and hereditary angioedema. Allergic angioedema results from allergic reactions to substances such as certain foods, insect stings, or medications. Treatments may be delivered via injection or oral administration and are used by various end users, including hospitals, clinics, and research institutions.

The angioedema treatment market research report is one of a series of new reports from The Business Research Company that provides angioedema treatment market statistics, including angioedema treatment industry global market size, regional shares, competitors with an angioedema treatment market share, detailed angioedema treatment market segments, market trends and opportunities, and any further data you may need to thrive in the angioedema treatment industry. This angioedema treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The angioedema treatment market size has grown rapidly in recent years. It will grow from $2.72 billion in 2024 to $3.13 billion in 2025 at a compound annual growth rate (CAGR) of 15.0%. The growth observed during the historic period can be attributed to increased government support, higher diagnosis rates, a surge in autoimmune disorders, expansion of clinical trials, and improvements in healthcare infrastructure.

The angioedema treatment market size is expected to see rapid growth in the next few years. It will grow to $5.40 billion in 2029 at a compound annual growth rate (CAGR) of 14.6%. The projected growth during the forecast period can be linked to rising healthcare expenditure, greater awareness of allergies, an increasing burden of chronic diseases, a higher incidence and prevalence of angioedema, and a growing emphasis on personalized medicine. Key trends expected in this period include advancements in diagnostic technologies, integration of machine learning, increased investments in research and development, the adoption of telemedicine, and accelerated regulatory approvals and market access.

An increase in the incidence of rare diseases is anticipated to drive the growth of the angioedema treatment market in the coming years. Rare diseases are medical conditions that affect a small percentage of the population and often present limited treatment options along with significant health challenges. This rise is largely due to advancements in genetic testing and diagnostic technologies, which enable more accurate identification and diagnosis of conditions that were previously undetected, resulting in a higher reported prevalence. Angioedema treatments play a vital role in managing rare diseases like hereditary angioedema by offering targeted therapies that help prevent and control severe swelling episodes, ultimately enhancing patient outcomes. For example, in November 2024, the U.S. Food and Drug Administration reported that over 7,000 rare diseases affect more than 30 million people in the United States. Thus, the growing incidence of rare diseases is contributing to the expansion of the angioedema treatment market.

Leading companies in the angioedema treatment market are prioritizing the development of innovative solutions, such as subcutaneous injections, to provide more convenient and rapid relief for patients experiencing acute hereditary angioedema (HAE) attacks. Subcutaneous injections deliver medication into the fatty tissue beneath the skin, allowing for gradual absorption into the bloodstream. For example, in April 2025, CSL Limited, an Australia-based biotechnology firm, introduced ANDEMBRY (garadacimab), a novel fully human monoclonal antibody designed to prevent acute HAE attacks. ANDEMBRY is the first pre-filled pen approved for once-monthly subcutaneous administration, offering a convenient long-term prophylactic option. The medication works by inhibiting activated Factor XII (Factor XIIa), a key component in the pathway that triggers angioedema. This innovation marks a major step forward in HAE treatment by delivering effective, patient-focused disease management.

In December 2023, Ionis Pharmaceuticals Inc., a U.S.-based biotechnology company, entered into a partnership with Otsuka Pharmaceutical Co., Ltd. to commercialize donidalorsen in Europe for the treatment of hereditary angioedema (HAE). The goal of this collaboration is to expedite the regulatory approval process and facilitate the launch of donidalorsen in the European market, leveraging Otsuka's regional expertise and established market presence. Otsuka Pharmaceutical Co., Ltd., a Japan-based pharmaceutical firm, provides treatments for hereditary angioedema and will play a key role in making this innovative therapy accessible to patients across Europe.

Major players in the angioedema treatment market are Sanofi SA, Takeda Pharmaceutical Company Limited, Viatris Inc., Otsuka Pharmaceutical Co. Ltd., Fresenius Kabi AG, Bausch Health Companies Inc., Apotex Inc., Aurobindo Pharma Ltd., Dr. Reddy's Laboratories Ltd, Cipla Inc., Alnylam Pharmaceuticals Inc, Ionis Pharmaceuticals Inc., Salix Pharmaceuticals Ltd, BioCryst Pharmaceuticals Inc., Pharming Group NV, Pharvaris Netherlands B.V, Astria Therapeutics, Intellia Therapeutics, KalVista Pharmaceuticals Ltd., ADARx Pharmaceuticals, Adverum Biotechnologies Inc.

North America was the largest region in the angioedema treatment market in 2024. The regions covered in angioedema treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the angioedema treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The angioedema treatment market consists of revenues earned by entities providing services, such as antihistamine administration, diagnostic services, corticosteroid therapy, genetic counseling, and immunology services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Angioedema Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on angioedema treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for angioedema treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The angioedema treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Allergic Angioedema; Drug-Induced Angioedema; Idiopathic Angioedema; Hereditary Angioedema
• 2) By Route Of Administration: Injection; Oral
• 3) By End Use: Hospitals; Clinics; Research Organizations
• 1) By Allergic Angioedema: Antihistamines; Corticosteroids; Epinephrine; Immunotherapy; Allergen Avoidance Therapies
• 2) By Drug-Induced Angioedema: Discontinuation of Causative Drug; Antihistamines; Corticosteroids; Epinephrine; Bradykinin Pathway Inhibitors
• 3) By Idiopathic Angioedema: Empirical Antihistamine Therapy; Corticosteroid Therapy; Leukotriene Receptor Antagonists; Monoclonal Antibodies; Observation and Symptom Management
• 4) By Hereditary Angioedema: C1 Esterase Inhibitor Replacement Therapy; Bradykinin B2 Receptor Antagonists; Kallikrein Inhibitors; Attenuated Androgens; Antifibrinolytics
• Companies Mentioned: Sanofi SA; Takeda Pharmaceutical Company Limited; Viatris Inc.; Otsuka Pharmaceutical Co. Ltd.; Fresenius Kabi AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Angioedema Treatment Market Characteristics

3. Angioedema Treatment Market Trends And Strategies

4. Angioedema Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Angioedema Treatment Growth Analysis And Strategic Analysis Framework

• 5.1. Global Angioedema Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Angioedema Treatment Market Growth Rate Analysis
• 5.4. Global Angioedema Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Angioedema Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Angioedema Treatment Total Addressable Market (TAM)

6. Angioedema Treatment Market Segmentation

• 6.1. Global Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Allergic Angioedema
• Drug-Induced Angioedema
• Idiopathic Angioedema
• Hereditary Angioedema (HAE)
• 6.2. Global Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Injection
• Oral
• 6.3. Global Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Clinics
• Research Organizations
• 6.4. Global Angioedema Treatment Market, Sub-Segmentation Of Allergic Angioedema, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antihistamines
• Corticosteroids
• Epinephrine
• Immunotherapy
• Allergen Avoidance Therapies
• 6.5. Global Angioedema Treatment Market, Sub-Segmentation Of Drug-Induced Angioedema, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Discontinuation of Causative Drug
• Antihistamines
• Corticosteroids
• Epinephrine
• Bradykinin Pathway Inhibitors
• 6.6. Global Angioedema Treatment Market, Sub-Segmentation Of Idiopathic Angioedema, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Empirical Antihistamine Therapy
• Corticosteroid Therapy
• Leukotriene Receptor Antagonists
• Monoclonal Antibodies
• Observation And Symptom Management
• 6.7. Global Angioedema Treatment Market, Sub-Segmentation Of Hereditary Angioedema, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• C1 Esterase Inhibitor Replacement Therapy
• Bradykinin B2 Receptor Antagonists
• Kallikrein Inhibitors
• Attenuated Androgens
• Antifibrinolytics

7. Angioedema Treatment Market Regional And Country Analysis

• 7.1. Global Angioedema Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Angioedema Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Angioedema Treatment Market

• 8.1. Asia-Pacific Angioedema Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Angioedema Treatment Market

• 9.1. China Angioedema Treatment Market Overview
• 9.2. China Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Angioedema Treatment Market

• 10.1. India Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Angioedema Treatment Market

• 11.1. Japan Angioedema Treatment Market Overview
• 11.2. Japan Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Angioedema Treatment Market

• 12.1. Australia Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Angioedema Treatment Market

• 13.1. Indonesia Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Angioedema Treatment Market

• 14.1. South Korea Angioedema Treatment Market Overview
• 14.2. South Korea Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Angioedema Treatment Market

• 15.1. Western Europe Angioedema Treatment Market Overview
• 15.2. Western Europe Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Angioedema Treatment Market

• 16.1. UK Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Angioedema Treatment Market

• 17.1. Germany Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Angioedema Treatment Market

• 18.1. France Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Angioedema Treatment Market

• 19.1. Italy Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Angioedema Treatment Market

• 20.1. Spain Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Angioedema Treatment Market

• 21.1. Eastern Europe Angioedema Treatment Market Overview
• 21.2. Eastern Europe Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Angioedema Treatment Market

• 22.1. Russia Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Angioedema Treatment Market

• 23.1. North America Angioedema Treatment Market Overview
• 23.2. North America Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Angioedema Treatment Market

• 24.1. USA Angioedema Treatment Market Overview
• 24.2. USA Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Angioedema Treatment Market

• 25.1. Canada Angioedema Treatment Market Overview
• 25.2. Canada Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Angioedema Treatment Market

• 26.1. South America Angioedema Treatment Market Overview
• 26.2. South America Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Angioedema Treatment Market

• 27.1. Brazil Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Angioedema Treatment Market

• 28.1. Middle East Angioedema Treatment Market Overview
• 28.2. Middle East Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Angioedema Treatment Market

• 29.1. Africa Angioedema Treatment Market Overview
• 29.2. Africa Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Angioedema Treatment Market Competitive Landscape And Company Profiles

• 30.1. Angioedema Treatment Market Competitive Landscape
• 30.2. Angioedema Treatment Market Company Profiles
  • 30.2.1. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Viatris Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Otsuka Pharmaceutical Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Fresenius Kabi AG Overview, Products and Services, Strategy and Financial Analysis

31. Angioedema Treatment Market Other Major And Innovative Companies

• 31.1. Bausch Health Companies Inc.
• 31.2. Apotex Inc.
• 31.3. Aurobindo Pharma Ltd.
• 31.4. Dr. Reddy's Laboratories Ltd
• 31.5. Cipla Inc.
• 31.6. Alnylam Pharmaceuticals Inc
• 31.7. Ionis Pharmaceuticals Inc.
• 31.8. Salix Pharmaceuticals Ltd
• 31.9. BioCryst Pharmaceuticals Inc.
• 31.10. Pharming Group NV
• 31.11. Pharvaris Netherlands B.V
• 31.12. Astria Therapeutics
• 31.13. Intellia Therapeutics
• 31.14. KalVista Pharmaceuticals Ltd.
• 31.15. ADARx Pharmaceuticals

32. Global Angioedema Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Angioedema Treatment Market

34. Recent Developments In The Angioedema Treatment Market

35. Angioedema Treatment Market High Potential Countries, Segments and Strategies

• 35.1 Angioedema Treatment Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Angioedema Treatment Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Angioedema Treatment Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer